Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study

医学 肺活量测定 优势比 横断面研究 人口 肺功能测试 肺活量 支气管扩张剂 气道 环境卫生 内科学 哮喘 麻醉 肺功能 病理 扩散能力
作者
Dan Xiao,Zhengming Chen,Sinan Wu,Kewu Huang,Jianying Xu,Lan Yang,Yongjian Xu,Xiangyan Zhang,Chunxue Bai,Jian Kang,Pixin Ran,Huahao Shen,Fuqiang Wen,Wan-zhen Yao,Tieying Sun,Guangliang Shan,Ting Yang,Yingxiang Lin,Jianguo Zhu,Ruiying Wang
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:8 (11): 1081-1093 被引量:186
标识
DOI:10.1016/s2213-2600(20)30155-7
摘要

Background Small airway dysfunction is a common but neglected respiratory abnormality. Little is known about its prevalence, risk factors, and prognostic factors in China or anywhere else in the world. We aimed to estimate the prevalence of small airway dysfunction using spirometry before and after bronchodilation, both overall and in specific population subgroups; assess its association with a range of lifestyle and environmental factors (particularly smoking); and estimate the burden of small airway dysfunction in China. Methods From June, 2012, to May, 2015, the nationally representative China Pulmonary Health study invited 57 779 adults to participate using a multistage stratified sampling method from ten provinces (or equivalent), and 50 479 patients with valid lung function testing results were included in the analysis. We diagnosed small airway dysfunction on the basis of at least two of the following three indicators of lung function being less than 65% of predicted: maximal mid-expiratory flow, forced expiratory flow (FEF) 50%, and FEF 75%. Small airway dysfunction was further categorised into pre-small airway dysfunction (defined as having normal FEV1 and FEV1/forced vital capacity [FVC] ratio before bronchodilator inhalation), and post-small airway dysfunction (defined as having normal FEV1 and FEV1/FVC ratio both before and after bronchodilator inhalation). Logistic regression yielded adjusted odds ratios (ORs) for small airway dysfunction associated with smoking and other lifestyle and environmental factors. We further estimated the total number of cases of small airway dysfunction in China by applying present study findings to national census data. Findings Overall the prevalence of small airway dysfunction was 43·5% (95% CI 40·7–46·3), pre-small airway dysfunction was 25·5% (23·6–27·5), and post-small airway dysfunction was 11·3% (10·3–12·5). After multifactor regression analysis, the risk of small airway dysfunction was significantly associated with age, gender, urbanisation, education level, cigarette smoking, passive smoking, biomass use, exposure to high particulate matter with a diameter less than 2·5 μm (PM2·5) concentrations, history of chronic cough during childhood, history of childhood pneumonia or bronchitis, parental history of respiratory diseases, and increase of body-mass index (BMI) by 5 kg/m2. The ORs for small airway dysfunction and pre-small airway dysfunction were similar, whereas larger effect sizes were generally seen for post-small airway dysfunction than for either small airway dysfunction or pre-small airway dysfunction. For post-small airway dysfunction, cigarette smoking, exposure to PM2·5, and increase of BMI by 5 kg/m2 were significantly associated with increased risk, among preventable risk factors. There was also a dose-response association between cigarette smoking and post-small airway dysfunction among men, but not among women. We estimate that, in 2015, 426 (95% CI 411–468) million adults had small airway dysfunction, 253 (238–278) million had pre-small airway dysfunction, and 111 (104–126) million had post-small airway dysfunction in China. Interpretation In China, spirometry-defined small airway dysfunction is highly prevalent, with cigarette smoking being a major modifiable risk factor, along with PM2·5 exposure and increase of BMI by 5 kg/m2. Our findings emphasise the urgent need to develop and implement effective primary and secondary prevention strategies to reduce the burden of this condition in the general population. Funding Ministry of Science and Technology of China; National Natural Science Foundation of China; National Health Commission of China.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
艾瑞克发布了新的文献求助10
4秒前
5秒前
忧伤的钥匙完成签到 ,获得积分10
5秒前
6秒前
YY发布了新的文献求助10
8秒前
李君然完成签到,获得积分10
9秒前
wqwweqwe发布了新的文献求助100
9秒前
Hunter完成签到,获得积分10
9秒前
喵斯完成签到,获得积分10
11秒前
Penn完成签到,获得积分10
13秒前
ireneadler完成签到,获得积分10
13秒前
活泼的诗桃完成签到,获得积分10
14秒前
深沉坤完成签到 ,获得积分10
15秒前
酷波er应助白木子衬采纳,获得10
15秒前
田様应助whisper采纳,获得10
17秒前
布丁完成签到 ,获得积分10
17秒前
Ava应助潇洒天亦采纳,获得10
18秒前
19秒前
务实的易梦完成签到,获得积分10
19秒前
wqwweqwe完成签到,获得积分10
20秒前
qi0625完成签到,获得积分10
21秒前
缥缈从霜发布了新的文献求助10
22秒前
ael发布了新的文献求助10
23秒前
迎风竹林下应助石林采纳,获得10
23秒前
whisper完成签到,获得积分10
24秒前
云飞扬应助fengruidage采纳,获得10
25秒前
AllRightReserved应助fengruidage采纳,获得10
25秒前
25秒前
面壁思过应助fengruidage采纳,获得10
25秒前
糯米多多发布了新的文献求助10
25秒前
沫栀完成签到,获得积分20
26秒前
26秒前
27秒前
爆米花应助Zhino采纳,获得10
27秒前
寒武纪完成签到,获得积分10
27秒前
27秒前
SciGPT应助luo采纳,获得10
28秒前
Sunyidan完成签到,获得积分10
30秒前
JC完成签到,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
晶种分解过程与铝酸钠溶液混合强度关系的探讨 8888
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6430210
求助须知:如何正确求助?哪些是违规求助? 8246276
关于积分的说明 17536348
捐赠科研通 5486453
什么是DOI,文献DOI怎么找? 2895834
邀请新用户注册赠送积分活动 1872228
关于科研通互助平台的介绍 1711749